China seeks to simplify device renewals and fast track novel products
This article was originally published in SRA
Executive Summary
The China Food and Drug Administration (formerly, the State Food and Drug Administration) has issued draft proposals to simplify the re-registration of medical devices and expedite the approval of certain novel products1.